These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 17452589)
1. Pilot trial of diltiazem in facioscapulohumeral muscular dystrophy. Elsheikh BH; Bollman E; Peruggia M; King W; Galloway G; Kissel JT Neurology; 2007 Apr; 68(17):1428-9. PubMed ID: 17452589 [No Abstract] [Full Text] [Related]
2. The relationship between regional body composition and quantitative strength in facioscapulohumeral muscular dystrophy (FSHD). Skalsky AJ; Abresch RT; Han JJ; Shin CS; McDonald CM Neuromuscul Disord; 2008 Nov; 18(11):873-80. PubMed ID: 18818077 [TBL] [Abstract][Full Text] [Related]
3. Fascioscapulohumeral muscular dystrophy: a progressive degenerative disease that responds to diltiazem. Lefkowitz DL; Lefkowitz SS Med Hypotheses; 2005; 65(4):716-21. PubMed ID: 15963657 [TBL] [Abstract][Full Text] [Related]
4. Assessment of regional body composition with dual-energy X-ray absorptiometry in Duchenne muscular dystrophy: correlation of regional lean mass and quantitative strength. Skalsky AJ; Han JJ; Abresch RT; Shin CS; McDonald CM Muscle Nerve; 2009 May; 39(5):647-51. PubMed ID: 19347922 [TBL] [Abstract][Full Text] [Related]
5. Development of a French isometric strength normative database for adults using quantitative muscle testing. Hogrel JY; Payan CA; Ollivier G; Tanant V; Attarian S; Couillandre A; Dupeyron A; Lacomblez L; Doppler V; Meininger V; Tranchant C; Pouget J; Desnuelle C Arch Phys Med Rehabil; 2007 Oct; 88(10):1289-97. PubMed ID: 17908571 [TBL] [Abstract][Full Text] [Related]
6. Diltiazem-induced photodistributed hyperpigmentation. Boyer M; Katta R; Markus R Dermatol Online J; 2003 Dec; 9(5):10. PubMed ID: 14996383 [TBL] [Abstract][Full Text] [Related]
7. Preventing hypotension effect of calcium channel blockers. Allen R Am Fam Physician; 2003 Mar; 67(5):940; author reply 940-1. PubMed ID: 12643354 [No Abstract] [Full Text] [Related]
9. Profound sinus bradycardia due to diltiazem, verapamil, and/or beta-adrenergic blocking drugs. Mills TA; Kawji MM; Cataldo VD; Pappas ND; O'Meallie LP; Breaux DM; Glancy DL J La State Med Soc; 2004; 156(6):327-31. PubMed ID: 15688675 [TBL] [Abstract][Full Text] [Related]
10. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy. Kan HE; Scheenen TW; Wohlgemuth M; Klomp DW; van Loosbroek-Wagenmans I; Padberg GW; Heerschap A Neuromuscul Disord; 2009 May; 19(5):357-62. PubMed ID: 19329315 [TBL] [Abstract][Full Text] [Related]
11. No effect of folic acid and methionine supplementation on D4Z4 methylation in patients with facioscapulohumeral muscular dystrophy. van der Kooi EL; de Greef JC; Wohlgemuth M; Frants RR; van Asseldonk RJ; Blom HJ; van Engelen BG; van der Maarel SM; Padberg GW Neuromuscul Disord; 2006 Nov; 16(11):766-9. PubMed ID: 17005397 [TBL] [Abstract][Full Text] [Related]
12. Mobility assessment of patients with facioscapulohumeral dystrophy. Iosa M; MazzĂ C; Frusciante R; Zok M; Aprile I; Ricci E; Cappozzo A Clin Biomech (Bristol, Avon); 2007 Dec; 22(10):1074-82. PubMed ID: 17850940 [TBL] [Abstract][Full Text] [Related]
13. Diltiazem and verapamil protect dystrophin-deficient muscle fibers of MDX mice from degeneration: a potential role in calcium buffering and sarcolemmal stability. Matsumura CY; Pertille A; Albuquerque TC; Santo Neto H; Marques MJ Muscle Nerve; 2009 Feb; 39(2):167-76. PubMed ID: 19145649 [TBL] [Abstract][Full Text] [Related]
14. Reticulated phototoxic eruption in a patient on long-term diltiazem therapy. Hanson M; Petronic-Rosic V J Drugs Dermatol; 2008 Aug; 7(8):792-3. PubMed ID: 18720699 [TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies. Morosetti R; Mirabella M; Gliubizzi C; Broccolini A; Sancricca C; Pescatori M; Gidaro T; Tasca G; Frusciante R; Tonali PA; Cossu G; Ricci E Stem Cells; 2007 Dec; 25(12):3173-82. PubMed ID: 17761758 [TBL] [Abstract][Full Text] [Related]
16. Hereditary pancreatitis amlodipine trial: a pilot study of a calcium-channel blocker in hereditary pancreatitis. Morinville VD; Lowe ME; Elinoff BD; Whitcomb DC Pancreas; 2007 Nov; 35(4):308-12. PubMed ID: 18090235 [TBL] [Abstract][Full Text] [Related]